NA Thyroid Cancer Diagnostics Market - Industry Trends and Forecast to 2030
North America Thyroid Cancer Diagnostics Market, By Product type (Instruments, Consumables & Accessories), Test Type (Imaging Test, Blood Test, Biopsy, Others), Cancer type (Papillary Carcinoma, Follicular Carcinoma, Others), Stages (Stage I, Stage II, Stage III, Stage IV), Age Group ( 30-65, 65 and above, 21-29, Below 21), End User (Hospitals, Associated Labs, Independent Diagnostic Laboratories, Diagnostic Imaging Centers, Cancer Research Institutes, Others), Distribution Channel (Direct Tender, Retail Sales), Country (U.S., Canada, Mexico) Industry Trends and Forecast to 2030
Market Definition:
Thyroid cancer is a type of cancer that begins in the par follicular and follicular thyroid cells of the thyroid gland. Thyroid cancer treatment options include surgical removal of the thyroid gland, radioactive ablation, and TSH suppression therapy. Iodine is absorbed by thyroid cells and converted into triiodothyronine (T3) and thyroxine. These hormones are released into the bloodstream and play an important role in the regulation of metabolism. A healthy thyroid gland produces approximately 80% T4 and 20% T3.
According to the American Cancer Society's most recent estimates for thyroid cancer in the United States for 2022 are: About 43,800 new cases of thyroid cancer (11,860 in men and 31,940 in women) About 2,230 deaths from thyroid cancer (1,070 men and 1,160 women). The increasing prevalence of thyroid cancer and the adoption of an unhealthy lifestyle are the factors for market growth.
Market Segmentation:
The North America thyroid cancer diagnostics market is categorized into seven notable segments based on product type, test type, cancer type, stages, age group, end user, and distribution channel.
• On the basis of product type, the North America thyroid cancer diagnostics market is segmented into instruments and consumables & accessories
• On the basis of test type, the North America thyroid cancer diagnostics market is segmented into imaging test, blood test, biopsy, and others
• On the basis of Cancer type, the North America thyroid cancer diagnostics market is segmented into papillary carcinoma, follicular carcinoma, others
• On the basis of Stage, North America thyroid cancer diagnostics market is segmented into Stage I, Stage II, Stage III, Stage IV)
• On the basis of Age group, North America thyroid cancer diagnostics market is segmented into 30-65, 65 and above, 21-29, below 21
• On the basis of end user, North America thyroid cancer diagnostics market is segmented into hospitals, associated labs, independent diagnostic laboratories, diagnostic imaging centers, cancer research institutes, others
• On the basis of distribution channel, North America thyroid cancer diagnostics market is segmented into direct tender and retail sales
Market Players
Some of the major players operating in the North America thyroid cancer diagnostics market are:
• Canon Inc.
• FUJIFILM Holdings Corporation
• F. Hoffmann-La Roche Ltd
• Quest Diagnostics Incorporated
• Illumina
• Koninklijke Philips N.V.
• Thermo Fisher Scientific Inc.
• Siemens Healthcare GmbH
• Abbott
• General Electric Company
• QIAGEN
• DIASORIN S.P.A.
• Merck KGaA
• Hologic
• Myriad Genetics Inc.
• BIOMERIEUX
• FONAR Corp.
• Time Medical Holding.
• MinFound Medical Systems Co., Ltd
- 1 Introduction
- 1.1 Objectives Of The Study
- 1.2 Market Definition
- 1.3 Overview Of The North America Thyroid Cancer Diagnostics Market
- 1.4 Limitations
- 1.5 Markets Covered
- 2 Market Segmentation
- 2.1 Markets Covered
- 2.2 Geographical Scope
- 2.3 Years Considered For The Study
- 2.4 Currency And Pricing
- 2.5 Dbmr Tripod Data Validation Model
- 2.6 Multivariate Modelling
- 2.7 Product Type Lifeline Curve
- 2.8 Primary Interviews With Key Opinion Leaders
- 2.9 Dbmr Market Position Grid
- 2.10 Market Testing Type Coverage Grid
- 2.11 Vendor Share Analysis
- 2.12 Secondary Sources
- 2.13 Assumptions
- 3 Executive Summary
- 4 Premium Insights
- 4.1 Pestel Analysis
- 4.2 Porter’s Five Forces
- 4.3 Growth Strategies Adopted By Key Market Players
- 5 Epidemiology
- 6 Regulatory Framework Of The North America Thyroid Cancer Diagnostics Market
- 6.1 Regulatory Scenario In The U.S.
- 6.2 Regulatory Scenario In Australia
- 6.3 Regulatory Scenario In Japan
- 6.4 Regulatory Scenario In China
- 7 Market Overview
- 7.1 Drivers
- 7.1.1 Rising Incidence And Prevalence Of Thyroid Nodules And Cancer
- 7.1.2 Rising Thyroid Cancer Diagnostic Tests
- 7.1.3 Rising Preference For Preventive Health Check-ups
- 7.1.4 Rising Awareness Towards Thyroid Cancer
- 7.2 Restraints
- 7.2.1 High Cost Of Diagnostics Procedure
- 7.2.2 Tissue Damage Due To High Radiation Exposure From Imaging Tests
- 7.3 Opportunities
- 7.3.1 Rise In Healthcare Expenditure For Cancer Diagnosis And Treatment
- 7.3.2 Rising Obese Population
- 7.4 Challenges
- 7.4.1 Stringent Regulatory Framework For The Approval And Commercialization Of Cancer Diagnostic Products
- 7.4.2 Lack Of Skilled And Certified Expertise
- 8 North America Thyroid Cancer Diagnostics Market, By Product Type
- 8.1 Overview
- 8.2 Instruments
- 8.2.1 Pathology Based Instruments
- 8.2.1.1 Pcr Instruments
- 8.2.1.2 Slide Staining Systems
- 8.2.1.3 Tissue Processing Systems
- 8.2.1.4 Cell Processors
- 8.2.1.5 Other Pathology-based Instruments
- 8.2.2 Imaging Instruments
- 8.2.2.1 Ultrasound Systems
- 8.2.2.2 Ct Systems
- 8.2.2.3 Mri Systems
- 8.2.2.4 Others
- 8.2.3 Biopsy Instruments
- 8.2.3.1 Needle Biopsy
- 8.2.3.2 Endoscopic Biopsy
- 8.2.3.3 Core Biopsy
- 8.2.3.4 Others
- 8.2.4 Others
- 8.3 Consumables & Accessories
- 8.3.1 Kits
- 8.3.1.1 Pcr Kits
- 8.3.1.2 Dna Polymerase Kits
- 8.3.1.3 Nucleic Acid Isolation Kits
- 8.3.1.4 Others
- 8.3.2 Reagents
- 8.3.2.1 Assays
- 8.3.2.2 Buffers
- 8.3.2.3 Primers
- 8.3.2.4 Others
- 8.3.3 Probes
- 8.3.4 Other Consumables
- 9 North America Thyroid Cancer Diagnostics Market, By Test Type
- 9.1 Overview
- 9.2 Imaging Test
- 9.2.1 Computed Tomography (Ct) Scan
- 9.2.2 Mri
- 9.2.3 Positron Emission Tomography (Pet) Scan
- 9.2.4 Others
- 9.3 Blood Test
- 9.3.1 Blood Chemistry Tests
- 9.3.2 Complete Blood Count (Cbc)
- 9.3.3 Others
- 9.4 Biopsy
- 9.4.1 Needle Biopsy
- 9.4.2 Bronchoscopy Biopsy
- 9.4.3 Core Biopsy
- 9.4.4 Others
- 9.5 Others
- 10 North America Thyroid Cancer Diagnostics Market, By Cancer Type
- 10.1 Overview
- 10.2 Papillary Carcinoma
- 10.3 Follicular Carcinoma
- 10.4 Others
- 11 North America Thyroid Cancer Diagnostics Market, By Stages
- 11.1 Overview
- 11.2 Stage I
- 11.3 Stage Ii
- 11.4 Stage Iii
- 11.5 Stage Iv
- 12 North America Thyroid Cancer Diagnostics Market, By Age Group
- 12.1 Overview
- 12.2 30-65
- 12.3 65 And Above
- 12.4 21-29
- 12.5 Below 21
- 13 North America Thyroid Cancer Diagnostics Market, By End User
- 13.1 Overview
- 13.2 Hospitals
- 13.3 Associated Labs
- 13.4 Independent Diagnostic Laboratories
- 13.5 Diagnostic Imaging Centers
- 13.6 Cancer Research Institutes
- 13.7 Others
- 14 North America Thyroid Cancer Diagnostics Market, By Distribution Channel
- 14.1 Overview
- 14.2 Direct Tender
- 14.3 Retail Sales
- 15 North America Thyroid Cancer Diagnostics Market, By Region
- 15.1 North America
- 15.1.1 U.S.
- 15.1.2 Canada
- 15.1.3 Mexico
- 16 North America Thyroid Cancer Diagnostics Market: Company Landscape
- 16.1 Company Share Analysis: North America
- 17 Swot Analysis
- 18 Company Profile
- 18.1 Canon Inc.
- 18.1.1 Company Snapshot
- 18.1.2 Company Share Analysis
- 18.1.3 Product Portfolio
- 18.1.4 Recent Developments
- 18.2 Fujifilm Corporation
- 18.2.1 Company Snapshot
- 18.2.2 Revenue Analysis
- 18.2.3 Company Share Analysis
- 18.2.4 Product Portfolio
- 18.2.5 Recent Development
- 18.3 F. Hoffmann-la Roche Ltd
- 18.3.1 Company Snapshot
- 18.3.2 Revenue Analysis
- 18.3.3 Company Share Analysis
- 18.3.4 Product Portfolio
- 18.3.5 Recent Development
- 18.4 Quest Diagnostics Incorporated
- 18.4.1 Company Snapshot
- 18.4.2 Revenue Analysis
- 18.4.3 Company Share Analysis
- 18.4.4 Product Portfolio
- 18.4.5 Recent Developments
- 18.5 Illumina, Inc.
- 18.5.1 Company Snapshot
- 18.5.2 Revenue Analysis
- 18.5.3 Company Share Analysis
- 18.5.4 Product Portfolio
- 18.5.5 Recent Development
- 18.6 Abbott
- 18.6.1 Company Snapshot
- 18.6.2 Revenue Analysis
- 18.6.3 Product Portfolio
- 18.6.4 Recent Development
- 18.7 Bd
- 18.7.1 Company Snapshot
- 18.7.2 Revenue Analysis
- 18.7.3 Product Portfolio
- 18.7.4 Recent Development
- 18.8 Beijing O&D Biotech Co., Ltd.
- 18.8.1 Company Snapshot
- 18.8.2 Product Portfolio
- 18.8.3 Recent Developments
- 18.9 Biomérieux Sa
- 18.9.1 Company Snapshot
- 18.9.2 Revenue Analysis
- 18.9.3 Product Portfolio
- 18.9.4 Recent Developments
- 18.10 Diasorin S.P.A.
- 18.10.1 Company Snapshot
- 18.10.2 Revenue Analysis
- 18.10.3 Product Portfolio
- 18.10.4 Recent Development
- 18.11 Fonar Corp.
- 18.11.1 Company Snapshot
- 18.11.2 Revenue Analysis
- 18.11.3 Product Portfolio
- 18.11.4 Recent Developments
- 18.12 General Electric
- 18.12.1 Company Snapshot
- 18.12.2 Revenue Analysis
- 18.12.3 Product Portfolio
- 18.12.4 Recent Developments
- 18.13 Hologic Inc.
- 18.13.1 Company Snapshot
- 18.13.2 Revenue Analysis
- 18.13.3 Product Portfolio
- 18.13.4 Recent Development
- 18.14 Koninklijke Philips N.V.
- 18.14.1 Company Snapshot
- 18.14.2 Revenue Analysis
- 18.14.3 Product Portfolio
- 18.14.4 Recent Development
- 18.15 Merck Kgaa.
- 18.15.1 Company Snapshot
- 18.15.2 Revenue Analysis
- 18.15.3 Product Portfolio
- 18.15.4 Recent Development
- 18.16 Medonica Co. Ltd
- 18.16.1 Company Snapshot
- 18.16.2 Product Portfolio
- 18.16.3 Recent Development
- 18.17 Minfound Medical Systems Co. Ltd
- 18.17.1 Company Snapshot
- 18.17.2 Product Portfolio
- 18.17.3 Recent Developments
- 18.18 Myriad Genetics, Inc.
- 18.18.1 Company Snapshot
- 18.18.2 Revenue Analysis
- 18.18.3 Product Portfolio
- 18.18.4 Recent Developments
- 18.19 Plexbio.
- 18.19.1 Company Snapshot
- 18.19.2 Product Portfolio
- 18.19.3 Recent Developments
- 18.20 Qiagen
- 18.20.1 Company Snapshot
- 18.20.2 Revenue Analysis
- 18.20.3 Product Portfolio
- 18.20.4 Recent Development
- 18.21 Sternmed Gmbh
- 18.21.1 Company Snapshot
- 18.21.2 Product Portfolio
- 18.21.3 Recent Developments
- 18.22 Siemens Healthcare Gmbh
- 18.22.1 Company Snapshot
- 18.22.2 Revenue Analysis
- 18.22.3 Product Portfolio
- 18.22.4 Recent Development
- 18.23 Time Medical Holding.
- 18.23.1 Company Snapshot
- 18.23.2 Product Portfolio
- 18.23.3 Recent Development
- 18.24 Thermo Fisher Scientific Inc.
- 18.24.1 Company Snapshot
- 18.24.2 Revenue Analysis
- 18.24.3 Product Portfolio
- 18.24.4 Recent Development
- 19 Questionnaire 213
- List Of Tables
- Table 1 North America Thyroid Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 2 North America Instruments In Thyroid Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 3 North America Instruments In Thyroid Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 4 North America Pathology-based Instruments In Thyroid Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 5 North America Imaging Instruments In Thyroid Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 6 North America Biopsy Instruments In Thyroid Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 7 North America Consumables & Accessories In Thyroid Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 8 North America Consumables & Accessories In Thyroid Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 9 North America Kits In Thyroid Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 10 North America Reagents In Thyroid Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 11 North America Thyroid Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
- Table 12 North America Imaging Test In Thyroid Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 13 North America Imaging Test In Thyroid Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
- Table 14 North America Blood Test In Thyroid Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 15 North America Blood Test In Thyroid Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
- Table 16 North America Biopsy In Thyroid Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 17 North America Biopsy In Thyroid Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
- Table 18 North America Others In Thyroid Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 19 North America Thyroid Cancer Diagnostics Market, By Cancer Type, 2021-2030 (Usd Million)
- Table 20 North America Papillary Carcinoma In Thyroid Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 21 North America Follicular Carcinoma In Thyroid Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 22 North America Others In Thyroid Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 23 North America Thyroid Cancer Diagnostics Market, By Stages, 2021-2030 (Usd Million)
- Table 24 North America Stage I In Thyroid Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 25 North America Stage Ii In Thyroid Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 26 North America Stage Iii In Thyroid Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 27 North America Stage Iv In Thyroid Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 28 North America Thyroid Cancer Diagnostics Market, By Age Group, 2021-2030 (Usd Million)
- Table 29 North America 30-65 In Thyroid Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 30 North America 65 And Above In Thyroid Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 31 North America 21-29 In Thyroid Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 32 North America Below 21 In Thyroid Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 33 North America Thyroid Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
- Table 34 North America Hospitals In Thyroid Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 35 North America Associated Labs In Thyroid Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 36 North America Independent Diagnostic Laboratories In Thyroid Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 37 North America Diagnostic Imaging Centers In Thyroid Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 38 North America Cancer Research Institutes In Thyroid Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 39 North America Others In Thyroid Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 40 North America Thyroid Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million)
- Table 41 North America Direct Tender In Thyroid Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 42 North America Retail Sales In Thyroid Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 43 North America Thyroid Cancer Diagnostics Market, By Country, 2021-2030 (Usd Million)
- Table 44 North America Thyroid Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 45 North America Instruments In Thyroid Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 46 North America Pathology-based Instruments In Thyroid Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 47 North America Imaging Instruments In Thyroid Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 48 North America Biopsy Instruments In Thyroid Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 49 North America Consumables & Accessories In Thyroid Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 50 North America Kits In Thyroid Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 51 North America Reagents In Thyroid Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 52 North America Thyroid Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
- Table 53 North America Imaging Test In Thyroid Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
- Table 54 North America Biopsy In Thyroid Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
- Table 55 North America Blood Test In Thyroid Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
- Table 56 North America Thyroid Cancer Diagnostics Market, By Cancer Type, 2021-2030 (Usd Million)
- Table 57 North America Thyroid Cancer Diagnostics Market, By Stages, 2021-2030 (Usd Million)
- Table 58 North America Thyroid Cancer Diagnostics Market, By Age Group, 2021-2030 (Usd Million)
- Table 59 North America Thyroid Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
- Table 60 North America Thyroid Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million)
- Table 61 U.S. Thyroid Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 62 U.S. Instruments In Thyroid Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 63 U.S. Pathology-based Instruments In Thyroid Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 64 U.S. Imaging Instruments In Thyroid Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 65 U.S. Biopsy Instruments In Thyroid Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 66 U.S. Consumables & Accessories In Thyroid Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 67 U.S. Kits In Thyroid Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 68 U.S. Reagents In Thyroid Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 69 U.S. Thyroid Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
- Table 70 U.S. Imaging Test In Thyroid Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
- Table 71 U.S. Biopsy In Thyroid Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
- Table 72 U.S. Blood Test In Thyroid Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
- Table 73 U.S. Thyroid Cancer Diagnostics Market, By Cancer Type, 2021-2030 (Usd Million)
- Table 74 U.S. Thyroid Cancer Diagnostics Market, By Stages, 2021-2030 (Usd Million)
- Table 75 U.S. Thyroid Cancer Diagnostics Market, By Age Group, 2021-2030 (Usd Million)
- Table 76 U.S. Thyroid Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
- Table 77 U.S. Thyroid Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million)
- Table 78 Canada Thyroid Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 79 Canada Instruments In Thyroid Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 80 Canada Pathology-based Instruments In Thyroid Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 81 Canada Imaging Instruments In Thyroid Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 82 Canada Biopsy Instruments In Thyroid Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 83 Canada Consumables & Accessories In Thyroid Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 84 Canada Kits In Thyroid Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 85 Canada Reagents In Thyroid Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 86 Canada Thyroid Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
- Table 87 Canada Imaging Test In Thyroid Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
- Table 88 Canada Biopsy In Thyroid Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
- Table 89 Canada Blood Test In Thyroid Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
- Table 90 Canada Thyroid Cancer Diagnostics Market, By Cancer Type, 2021-2030 (Usd Million)
- Table 91 Canada Thyroid Cancer Diagnostics Market, By Stages, 2021-2030 (Usd Million)
- Table 92 Canada Thyroid Cancer Diagnostics Market, By Age Group, 2021-2030 (Usd Million)
- Table 93 Canada Thyroid Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
- Table 94 Canada Thyroid Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million)
- Table 95 Mexico Thyroid Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 96 Mexico Instruments In Thyroid Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 97 Mexico Pathology-based Instruments In Thyroid Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 98 Mexico Imaging Instruments In Thyroid Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 99 Mexico Biopsy Instruments In Thyroid Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 100 Mexico Consumables & Accessories In Thyroid Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 101 Mexico Kits In Thyroid Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 102 Mexico Reagents In Thyroid Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 103 Mexico Thyroid Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
- Table 104 Mexico Imaging Test In Thyroid Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
- Table 105 Mexico Biopsy In Thyroid Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
- Table 106 Mexico Blood Test In Thyroid Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
- Table 107 Mexico Thyroid Cancer Diagnostics Market, By Cancer Type, 2021-2030 (Usd Million)
- Table 108 Mexico Thyroid Cancer Diagnostics Market, By Stages, 2021-2030 (Usd Million)
- Table 109 Mexico Thyroid Cancer Diagnostics Market, By Age Group, 2021-2030 (Usd Million)
- Table 110 Mexico Thyroid Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
- Table 111 Mexico Thyroid Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million) 140
- List Of Figures
- Figure 1 North America Thyroid Cancer Diagnostics Market: Segmentation
- Figure 2 North America Thyroid Cancer Diagnostics Market: Data Triangulation
- Figure 3 North America Thyroid Cancer Diagnostics Market: Droc Analysis
- Figure 4 North America Thyroid Cancer Diagnostics Market: North America Vs Regional Market Analysis
- Figure 5 North America Thyroid Cancer Diagnostics Market: Company Research Analysis
- Figure 6 North America Thyroid Cancer Diagnostics Market: Interview Demographics
- Figure 7 North America Thyroid Cancer Diagnostics Market: Dbmr Market Position Grid
- Figure 8 North America Thyroid Cancer Diagnostics Market: Market Testing Type Coverage Grid
- Figure 9 North America Thyroid Cancer Diagnostics Market: Vendor Share Analysis
- Figure 10 North America Thyroid Cancer Diagnostics Market: Segmentation
- Figure 11 The Increase In The Awareness About Thyroid Cancer Is Expected To Drive The North America Thyroid Cancer Diagnostics Market In The Forecast Period
- Figure 12 Product Type Segment Is Expected To Account For The Largest Share Of The North America Thyroid Cancer Diagnostics Market In 2023 & 2030
- Figure 13 Drivers, Restraints, Opportunities, And Challenges Of North America Thyroid Cancer Diagnostics Market
- Figure 14 North America Thyroid Cancer Diagnostics Market: By Product Type, 2022
- Figure 15 North America Thyroid Cancer Diagnostics Market: By Product Type, 2023-2030 (Usd Million)
- Figure 16 North America Thyroid Cancer Diagnostics Market: By Product Type, Cagr (2023-2030)
- Figure 17 North America Thyroid Cancer Diagnostics Market: By Product Type, Lifeline Curve
- Figure 18 North America Thyroid Cancer Diagnostics Market: By Test Type, 2022
- Figure 19 North America Thyroid Cancer Diagnostics Market: By Test Type, 2023-2030 (Usd Million)
- Figure 20 North America Thyroid Cancer Diagnostics Market: By Test Type, Cagr (2023-2030)
- Figure 21 North America Thyroid Cancer Diagnostics Market: By Test Type, Lifeline Curve
- Figure 22 North America Thyroid Cancer Diagnostics Market: By Cancer Type, 2022
- Figure 23 North America Thyroid Cancer Diagnostics Market: By Cancer Type, 2023-2030 (Usd Million)
- Figure 24 North America Thyroid Cancer Diagnostics Market: By Cancer Type, Cagr (2023-2030)
- Figure 25 North America Thyroid Cancer Diagnostics Market: By Cancer Type, Lifeline Curve
- Figure 26 North America Thyroid Cancer Diagnostics Market: By Stages, 2022
- Figure 27 North America Thyroid Cancer Diagnostics Market: By Stages, 2023-2030 (Usd Million)
- Figure 28 North America Thyroid Cancer Diagnostics Market: By Stages, Cagr (2023-2030)
- Figure 29 North America Thyroid Cancer Diagnostics Market: By Stages, Lifeline Curve
- Figure 30 North America Thyroid Cancer Diagnostics Market: By Age Group, 2022
- Figure 31 North America Thyroid Cancer Diagnostics Market: By Age Group, 2023-2030 (Usd Million)
- Figure 32 North America Thyroid Cancer Diagnostics Market: By Age Group, Cagr (2023-2030)
- Figure 33 North America Thyroid Cancer Diagnostics Market: By Age Group, Lifeline Curve
- Figure 34 North America Thyroid Cancer Diagnostics Market: By End User, 2022
- Figure 35 North America Thyroid Cancer Diagnostics Market: By End User, 2023-2030 (Usd Million)
- Figure 36 North America Thyroid Cancer Diagnostics Market: By End User, Cagr (2023-2030)
- Figure 37 North America Thyroid Cancer Diagnostics Market: By End User, Lifeline Curve
- Figure 38 North America Thyroid Cancer Diagnostics Market: By Distribution Channel, 2022
- Figure 39 North America Thyroid Cancer Diagnostics Market: By Distribution Channel, 2023-2030 (Usd Million)
- Figure 40 North America Thyroid Cancer Diagnostics Market: By Distribution Channel, Cagr (2023-2030)
- Figure 41 North America Thyroid Cancer Diagnostics Market: By Distribution Channel, Lifeline Curve
- Figure 42 North America Thyroid Cancer Diagnostics Market: Snapshot (2022)
- Figure 43 North America Thyroid Cancer Diagnostics Market: By Country (2022)
- Figure 44 North America Thyroid Cancer Diagnostics Market: By Country (2023 & 2030)
- Figure 45 North America Thyroid Cancer Diagnostics Market: By Country (2022 & 2030)
- Figure 46 North America Thyroid Cancer Diagnostics Market: Product Type (2023-2030)
- Figure 47 North America Thyroid Cancer Diagnostics Market: Company Share 2022 (%) 139
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook